Prime Medicine PRME
NASDAQ PRME
$4.30 +0.40 (+10.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Prime Medicine (PRME) Common Stock Issued (2022 - 2026)

Updated

Analysis

Prime Medicine (PRME) Common Stock Issued (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Prime Medicine 704.88 Mn 469.45 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,000.00
Mar 31, 2026 393,000.00
Sep 30, 2024 38.11 Mn
Jun 30, 2024 35,000.00
Mar 31, 2024 150.89 Mn
Dec 31, 2023 194,000.00
Sep 30, 2023 318,000.00
Jun 30, 2023 75,000.00
Mar 31, 2023 68,000.00
Dec 31, 2022 185.47 Mn
Sep 30, 2022 63,000.00
API Access

Prime Medicine Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=PRME&period=max&api_key=YOUR_API_KEY